BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Laser capture microdissection
,
Doxycycline
,
rs2230926
,
BRCA1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukin 2 receptor
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
CD8+ T cells anti-CD3 CD28 activated then stimulated with IL-2 or IL-2 variants H9 or H9-RET
Natural killer cells treated with interleukin-2 or 15 and then with or without cytokine withdrawal
Drug target sets for approved compounds
Expression data from Murine T cell in response to cycloheximide treatment
Activation of Sez-4 T-cell lymphoma cell line with IL-2, IL-15 or IL-21
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases.
Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on…
Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict …
Soluble interleukin-2 receptor as a predictive and prognostic marker for patients with familial brea…
Bypassing the cytokine sink: IL-2-independent IL-2 receptor signaling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb…
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Be…
Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hod…
Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Le…
Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ